For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Sanlorenzo boasts strong fundamentals and a resilient business model. Find out why SNLRF stock is a strong buy at current ...

These are crucial S&P 500 chart levels to watch after the benchmark stock index tumbled into correction on Thursday for the ...

The S&P 500 is now more than 10 percent below its last record high — a line in the sand for investors worried about a ...

For the first time in over a year, the U.S. stock market is in a correction. The question now is whether the slide is set to ...

Acelyrin (NASDAQ:SLRN) stock in focus as the company adopts a poison pill to counter rapid stock acquisition by Tang Capital Partners. Read more here.

The Rights Plan is effective immediately and will expire on March 12, 2026. ACELYRIN stockholders do not need to take any further action at this time.

Loop Capital analyst Mark Schappel lowered the firm’s price target on Palantir (PLTR) to $125 from $141 and keeps a Buy rating on the shares.

This Unstoppable Stock Obliterated the S&P 500 in 2024, and It's Soaring Again in 2025. Here's Why It's Not too Late to Buy.

Readers hoping to buy SLP Resources Berhad ( KLSE:SLP ) for its dividend will need to make their move shortly, as ...

Skycorp Solar Group priced its initial public offering of 2 million shares at $4 each, for total proceeds of $8 million. The solar photovoltaic product provider said the shares have been approved for ...

Patanjali share price drops 11% on Feb 28, causing panic among investors amid market concerns and regulatory challenges.